Borrow it
Coverart for item
The Resource Evidence synthesis for determining the responsiveness of depression questionnaires and optimal treatment duration for antidepressant medications, investigators, John W. Williams Jr. ... [et al.], (electronic book)

Evidence synthesis for determining the responsiveness of depression questionnaires and optimal treatment duration for antidepressant medications, investigators, John W. Williams Jr. ... [et al.], (electronic book)

Contributor
Summary
In 2000, the U.S. economic burden of depressive disorders was estimated to be 83.1 billion dollars. This included 31% direct medical costs, 7% suicide-related mortality costs, and 62% workplace costs. A variety of strategies have been tested to improve patient outcomes. Among these, integrated care models have emerged as both effective and cost effective. A recent systematic review identifies symptom monitoring as a key element of these integrated care models. However, the review did not identify the standardized depression scales that are responsive to clinically important change. A separate but important issue raised by Veterans Administration (VA) Stakeholders is how long to continue antidepressant medication for patients who respond to acute phase treatment. Clinical guidelines recommend continuation treatment for 4-6 months for uncomplicated major depression and some national performance measures are linked to these guidelines. However, clinical guidelines for longer-term maintenance phase treatment are more variable and performance indicators (e.g., Healthcare Effectiveness Data and Information Set, HEDIS) do not address maintenance phase treatment. A better understanding of the evidence for long-term treatment efficacy with antidepressants would inform guidelines and performance measurement. The Key Questions (KQ) were: KQ1: In patients with major depressive disorder treated in primary care settings, what assessment tools are responsive to change? This review should specifically address instruments that are feasible for the primary care setting. KQ2: In primary care patients with major depressive disorder who remit with antidepressant medication, what is the minimum treatment duration to decrease the risk of relapse or recurrence? This review will focus on patients without comorbid substance abuse, PTSD, psychosis or other conditions where guidelines would recommend specialty based care
Language
  • eng
  • eng
Work
Publication
Note
"Prepared for: Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Durham Veterans Affairs Medical Center/Duke Evidence-based Practice Center, Durham, NC."
Instance
Label
Evidence synthesis for determining the responsiveness of depression questionnaires and optimal treatment duration for antidepressant medications
Title
Evidence synthesis for determining the responsiveness of depression questionnaires and optimal treatment duration for antidepressant medications
Statement of responsibility
investigators, John W. Williams Jr. ... [et al.]
Contributor
Subject
Language
  • eng
  • eng
Summary
In 2000, the U.S. economic burden of depressive disorders was estimated to be 83.1 billion dollars. This included 31% direct medical costs, 7% suicide-related mortality costs, and 62% workplace costs. A variety of strategies have been tested to improve patient outcomes. Among these, integrated care models have emerged as both effective and cost effective. A recent systematic review identifies symptom monitoring as a key element of these integrated care models. However, the review did not identify the standardized depression scales that are responsive to clinically important change. A separate but important issue raised by Veterans Administration (VA) Stakeholders is how long to continue antidepressant medication for patients who respond to acute phase treatment. Clinical guidelines recommend continuation treatment for 4-6 months for uncomplicated major depression and some national performance measures are linked to these guidelines. However, clinical guidelines for longer-term maintenance phase treatment are more variable and performance indicators (e.g., Healthcare Effectiveness Data and Information Set, HEDIS) do not address maintenance phase treatment. A better understanding of the evidence for long-term treatment efficacy with antidepressants would inform guidelines and performance measurement. The Key Questions (KQ) were: KQ1: In patients with major depressive disorder treated in primary care settings, what assessment tools are responsive to change? This review should specifically address instruments that are feasible for the primary care setting. KQ2: In primary care patients with major depressive disorder who remit with antidepressant medication, what is the minimum treatment duration to decrease the risk of relapse or recurrence? This review will focus on patients without comorbid substance abuse, PTSD, psychosis or other conditions where guidelines would recommend specialty based care
Member of
Cataloging source
DNLM
http://bibfra.me/vocab/relation/checktag
bWsWsauV6K8
Government publication
federal national government publication
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • surveys of literature
  • technical reports
http://library.link/vocab/relatedWorkOrContributorName
  • Williams, John W.
  • United States
  • Durham VA Medical Center
  • Duke University Evidence-based Practice Center
Series statement
Evidence-based sysnthesis program
http://library.link/vocab/subjectName
  • Depressive Disorder, Major
  • Dose-Response Relationship, Drug
  • Psychiatric Status Rating Scales
  • Questionnaires
  • Recurrence
  • Depressive Disorder, Major
  • Antidepressive Agents
  • Treatment Outcome
  • Drug Administration Schedule
  • Primary Health Care
  • Randomized Controlled Trials as Topic
  • Time Factors
  • Humans
  • United States
Label
Evidence synthesis for determining the responsiveness of depression questionnaires and optimal treatment duration for antidepressant medications, investigators, John W. Williams Jr. ... [et al.], (electronic book)
Instantiates
Publication
Note
"Prepared for: Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Durham Veterans Affairs Medical Center/Duke Evidence-based Practice Center, Durham, NC."
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
1542138
Dimensions
unknown
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote
Label
Evidence synthesis for determining the responsiveness of depression questionnaires and optimal treatment duration for antidepressant medications, investigators, John W. Williams Jr. ... [et al.], (electronic book)
Publication
Note
"Prepared for: Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Durham Veterans Affairs Medical Center/Duke Evidence-based Practice Center, Durham, NC."
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
1542138
Dimensions
unknown
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote

Subject

Member of

Library Locations

Library Links

Structured data from the Bibframe namespace is licensed under the Creative Commons Attribution 4.0 International License by University of Liverpool. Additional terms may apply to data associated with third party namespaces.
Processing Feedback ...